3-(4-Oxo-3,4-dihydroquinazolin-2-yl)-N-(4-sulfamoylphenyl)propanamide

Catalog No. :
ACQNPS498
CAS No. :
731801-19-7
Molecular Formula :
C17H16N4O4S
Molecular Weight :
372.41

IUPAC Name:3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N-(4-sulfamoylphenyl)propanamide

3-(4-Oxo-3,4-dihydroquinazolin-2-yl)-N-(4-sulfamoylphenyl)propanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$291.00Login to see priceIn stockInquiry
250mg98%$493.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-Oxo-3,4-dihydroquinazolin-2-yl)-N-(4-sulfamoylphenyl)propanamide
IUPAC Name3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N-(4-sulfamoylphenyl)propanamide
Molecular FormulaC17H16N4O4S
Molecular Weight372.41
SMILESNS(=O)(C1=CC=C(C=C1)NC(CCC2=NC3=C(C(N2)=O)C=CC=C3)=O)=O
InChI KeyOZFGRIAGSCXGBD-UHFFFAOYSA-N
Synonym2-Quinazolinepropanamide, N-[4-(aminosulfonyl)phenyl]-3,4-dihydro-4-oxo-;3-(4-Oxo-3,4-dihydroquinazolin-2-yl)-N-(4-sulfamoylphenyl)propanamide;WAY-620298
CAS No.731801-19-7
PubChem CID135431128

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACQNPS498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKIP713 route compound structure diagram
    ACYKIP7136101-31-1 In Stock
  2. Plus
  3. ACVIHJ458 route compound structure diagram
    ACVIHJ4585368-37-6 In Stock
  4. Then
  5. ACQNPS498 route product structure diagram
    ACQNPS498731801-19-7 In Stock
Inquiry

2. ACQNPS498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQNPS498 route product structure diagram
    ACQNPS498731801-19-7 In Stock
Inquiry

Comments (0)